Markers of NASH-like tissue inhibitors of metalloproteinase-1 (Timp1), vimentin (Vim), matrix metallopeptidase 2 (Mmp2), and matrix metallopeptidase 9 (Mmp9) were significantly reduced by SZ-A (Figure 3I). Here, MMP9 is linked to metabolic dysfunction-associated steatohepatitis.